2nd Quarter - Report

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Firm
Client
Income
—
Expenses
$250,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies.

LobbyistCovered position, as disclosed
MAURA FARRELL —
MICHAEL KEEGAN New —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); SENATE

Health Issues HCR

Issues pertaining to health information technology and electronic health records (EHR); in general. Coalition comment letter to the Office of the National Coordinator (ONC)for Health Information Technology at the Dept. of Health and Human Services (HHS) regarding the draft Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHR. Coalition letter to Administrator of the Maternal and Child Health Bureau within the Health Resources and Services Administration (HRSA)requesting a meeting to discuss issues around the Early Hearing and Detection Intervention (EHDI) program. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Committee on Ways and Means regarding surprise out-of-network bills. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues related to hearing healthcare; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to scope of practice; in general. H.Res.147, Expressing Support for the Designation of March 3, 2019, as World Hearing Day. Issues pertaining to Graduate Medical Education; in general. Coalition letter addressed to the House calling on policymakers to address the growing physician shortage by passing H.R. 1763, the Resident Physician Shortage Reduction Act of 2019. Coalition letter addressed to the Senate calling on policymakers to address the growing physician shortage by passing S.348, the Resident Physician Shortage Reduction Act of 2019. Coalition letter thanking Dr. Warren, Associate Administrator of Bureau of Maternal and Child Health for meeting with Audiology and Hearing groups on March 22 regarding support for families in need of assistive hearing technologies and communication modalities. Coalition Letter addressed to the National Coordinator for Health Information Technology regarding the ONC's proposed rule to implement certain provisions of the 21st Century Cures Act. Coalition Letter addressed to the Administrator of Centers for Medicare & Medicaid Services regarding the CMS's proposed rule to improve interoperability and access to health care data.

LobbyistCovered position, as disclosed
MAURA FARRELL —
MICHAEL KEEGAN New —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: SENATE; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Bills named: H.Res. 147 (116th), S. 348 (116th), H.R. 1763 (116th)

Medicare/Medicaid MMM

Issues pertaining to health information technology and electronic health records; in general. Coalition letter to CMS Administrator urging CMS to provide guidance to Medicare Advantage plans on prior authorization through its 2020 Call Letter. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Committee on Ways and Means regarding surprise out-of-network bills. Issues pertaining to surprise out-of-network bills; in general. Coalition letter addressed to the Director of the Office for Civil Rights (OCR) within the Dept. of Health and Human Services (HHS) regarding a RFIon "Modifying HIPPAA Rules to Improve Coordinated Care." Issues related to prior authorization, in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues related to hearing healthcare; in general. Issues pertaining to scope of practice; in general. Coalition letter addressed to the House calling on policymakers to address the growing physician shortage by passing H.R. 1763, the Resident Physician Shortage Reduction Act of 2019. Coalition letter addressed to the Senate calling on policymakers to address the growing physician shortage by passing S.348, the Resident Physician Shortage Reduction Act of 2019. Coalition letter addressed to the Speaker of the House and Minority Leader urging Congress to make further refinements to improve MACRA, including replacing the 2020-2025 physician payment update freeze with positive payment adjustments for physicians. Coalition letter addressed to the Senate Majority Leader and Minority Leader urging Congress to make further refinements to improve MACRA, including replacing the 2020-2025 physician payment update freeze with positive payment adjustments for physicians.

LobbyistCovered position, as disclosed
MAURA FARRELL —
MICHAEL KEEGAN New —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Bills named: S. 348 (116th), H.R. 1763 (116th)

Budget/Appropriations BUD

Coalition letter addressed to the Chair and Ranking Member of the U.S. House of Representatives Appropriations Subcommittee on Labor, Health,and Human Services, Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.

LobbyistCovered position, as disclosed
MAURA FARRELL —
MICHAEL KEEGAN New —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); SENATE; Medicare Payment Advisory Commission (MedPAC)

Tobacco TOB

Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies. Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman of the House Energy and Commerce Committee expressing support for H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019.

LobbyistCovered position, as disclosed
MAURA FARRELL —
MICHAEL KEEGAN New —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2339 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.